Rhopressa for Corneal Edema Associated With Fuchs Dystrophy

Clinical trial NCT04051463 · COMPLETED

Trial details

NCT number: NCT04051463
Sponsor: Price Vision Group
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Fuchs Endothelial Dystrophy

Start date: 2019-08-05
Primary completion: 2020-07-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.